CLINICAL_TRIALS
trial_result
· 2019-10-01
Clinical Trial Update: Roflumilast in Non-CF Bronchiectasis Study [Phase 2]
Summary
Phase 2 trial update for roflumilast in non-cystic fibrosis bronchiectasis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Hong Kong | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 2 | Status: COMPLETED